 Anti-Obesity Agents
"Anti-Obesity Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (NIDDM) to treat obesity.
| Descriptor ID |
D019440
|
| MeSH Number(s) |
D27.505.954.427.140
|
| Concept/Terms |
Anti-Obesity Agents- Anti-Obesity Agents
- Agents, Anti-Obesity
- Anti Obesity Agents
- Anti-Obesity Drugs
- Anti Obesity Drugs
- Drugs, Anti-Obesity
- Antiobesity Drugs
- Drugs, Antiobesity
- Antiobesity Agents
- Agents, Antiobesity
Weight-Loss Agents- Weight-Loss Agents
- Agents, Weight-Loss
- Weight Loss Agents
- Weight-Loss Drugs
- Drugs, Weight-Loss
- Weight Loss Drugs
|
Below are MeSH descriptors whose meaning is more general than "Anti-Obesity Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Obesity Agents".
This graph shows the total number of publications written about "Anti-Obesity Agents" by people in this website by year, and whether "Anti-Obesity Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 2 | 0 | 2 | | 2002 | 1 | 0 | 1 | | 2004 | 1 | 1 | 2 | | 2006 | 0 | 1 | 1 | | 2008 | 0 | 2 | 2 | | 2009 | 1 | 2 | 3 | | 2012 | 2 | 0 | 2 | | 2013 | 2 | 2 | 4 | | 2014 | 1 | 1 | 2 | | 2015 | 2 | 0 | 2 | | 2016 | 3 | 1 | 4 | | 2018 | 2 | 2 | 4 | | 2019 | 3 | 0 | 3 | | 2021 | 1 | 1 | 2 | | 2023 | 4 | 0 | 4 | | 2024 | 2 | 3 | 5 | | 2025 | 2 | 0 | 2 | | 2026 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Obesity Agents" by people in Profiles.
-
Miller JL, van Santen HM, Phillips SA, Hamilton J, Aberle J, Sathyapalan T, Mohamed Z, McCormack SE, Shoemaker AH, Kelsey MM, Ghalib L, Stalla G, Thaker VV, Habiby R, Ode KL, Wabitsch M, Dattani M, Abuzzahab MJ, Abdullatif H, Morgan R, Stefater-Richards M, Aroda VR, Friedrich C, Han JC, Ono H, Nagasaki K, Tanaka T, Isojima T, Arima H, Scimia C, Yuan G, Müller HL, Roth CL. Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. N Engl J Med. 2026 Jul 09; 395(2):138-150.
-
DiStefano MJ, Tilley A, Paratane D, Gyimah Gyamfi H, Moore GD, Nair KV. Postshortage Compounded GLP-1 RA Market in 2 States With Potentially High Demand. JAMA Health Forum. 2026 Jul 02; 7(7):e262207.
-
Doan TT, Mueller HJ, Avanceña ALV, Peyyety V, Bensignor MO, Vajravelu ME. Cost-Effectiveness of Access to Obesity Care and Treatments for Adolescents. Child Obes. 2026 Sep; 22(6):379-388.
-
Chao AM, Gilden A, Wadden TA. Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety. PLoS Med. 2026 Jan; 23(1):e1004871.
-
McGinnis T, McCallum M, Pan Z, Cunningham C, Saxon DR, Thomas E. Clinical Effectiveness of Semaglutide for Weight Loss in a Veterans Affairs' Anti-Obesity Pharmacotherapy Clinic. J Gen Intern Med. 2026 05; 41(6):1547-1555.
-
Batt CE, Puccio OC, Kelsey MM, Boles RE, Moore JM. Real-World Use of Phentermine and Topiramate for Adolescent Obesity: Retrospective Effectiveness and Safety Analysis. Child Obes. 2025 10; 21(7):580-588.
-
Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, Wilding JPH, Perreault L, Zhang S, Battula R, Bunck MC, Ahmad NN, Jouravskaya I. Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2025 Mar 06; 392(10):958-971.
-
Armstrong SC, Eneli I, Osganian SK, Wagner BE, Waldrop SW, Kelly AS. Pediatric Obesity Pharmacotherapy: State of the Science, Research Gaps, and Opportunities. Pediatrics. 2024 Nov 01; 154(5).
-
Vidmar AP, Batt CE, Moore JM. Assessment and medical management of weight regain after adolescent metabolic and bariatric surgery: a narrative review. Surg Obes Relat Dis. 2025 01; 21(1):24-32.
-
Gilden AH, Catenacci VA, Taormina JM. Obesity. Ann Intern Med. 2024 05; 177(5):ITC65-ITC80.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|